# Multi-Center Study of New Medications to Treat Vaginal Infections

> **NCT02308033** · PHASE3 · COMPLETED · sponsor: **Curatek Pharmaceuticals, LLC** · enrollment: 204 (actual)

## Conditions studied

- Vaginal Infection

## Interventions

- **DRUG:** Metronidazole
- **DRUG:** Gel vehicle

## Key facts

- **NCT ID:** NCT02308033
- **Lead sponsor:** Curatek Pharmaceuticals, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2017-06
- **Final completion:** 2017-06
- **Target enrollment:** 204 (ACTUAL)
- **Last updated:** 2020-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02308033

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02308033, "Multi-Center Study of New Medications to Treat Vaginal Infections". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02308033. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*